Skip to main content

Meet the Editorial and Advisory Boards

Editorial Board

Our international Editorial Board provides expert commissioning guidance and insight into their specific topic areas to the in-house editorial team.

Axel S Merseburger

Dr Merseburger is currently Professor and Chairman of the Clinic of Urology at University Hospital Schleswig-Holstein in Lübeck, Germany, having previously served as Vice Chairman of the Department of Urologic Oncology and Director of the Urologic Oncology Programme at Hannover Medical School, Germany. Dr Merseburger’s key areas of interest are renal cell carcinoma, prostate cancer and transitional cell carcinoma, with special attention given to novel markers and prognostic factors. He is a principal investigator in German Phase II and III trials.

Fiona Blackhall

Dr Blackhall is a Professor of Thoracic Oncology with expertise in personalized medicine and circulating biomarkers within the Institute of Cancer Studies, University of Manchester and has been a Consultant Medical Oncologist at The Christie Hospital, Manchester since 2005. She has conducted over 50 therapeutic clinical trials, including practice-changing precision medicine studies, and led on new directions in radiotherapy-related research and supportive palliative care research.

Advisory Board

Our international Advisory Board provides additional support and expert insight into specific topic areas to the Editorial Board and in-house editorial team.

Working with local colleagues in their regions, they also ensure that regional sites provide up-to-date information and opinion on clinical practice relevant to local healthcare professionals.

Image Credits